Boston Scientific Corporation vs Match Group Inc — how do they compare? Boston Scientific Corporation trades at $50.96 (market cap $74.19B), while Match Group Inc trades at $37 (market cap $8.45B). The key difference: Boston Scientific Corporation is far larger — about 8.8× Match Group Inc's market cap, and Match Group Inc pays a 2.17% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | MTCH | |
|---|---|---|
Market Cap | $74.19B | $8.45B |
Sector | Health | Media |
52-Week High | $108.14 | $41.24 |
52-Week Low | $42.63 | $28.90 |
Enterprise Value | $86.27B | $11.42B |
Dividend Yield | — | 2.17% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →